Role of endothelial cells in graft-versus-host disease
To date, the only curative treatment for high-risk or refractory hematologic malignancies non-responsive to standard chemotherapy is allogeneic hematopoietic transplantation (allo-HCT). Acute graft-versus-host disease (GVHD) is a donor T cell-mediated immunological disorder that is frequently fatal...
Main Authors: | Lotus Neidemire-Colley, Jérémy Robert, Antoine Ackaoui, Adrienne M. Dorrance, Martin Guimond, Parvathi Ranganathan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1033490/full |
Similar Items
-
Corrigendum: Role of endothelial cells in graft-versus-host disease
by: Lotus Neidemire-Colley, et al.
Published: (2023-01-01) -
Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease
by: Katiri J. Snyder, et al.
Published: (2021-10-01) -
Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?
by: Giuseppe Lia, et al.
Published: (2021-05-01) -
T-Cell Metabolism in Graft Versus Host Disease
by: Franziska Karl, et al.
Published: (2021-10-01) -
Acute graft versus host disease 1976–2020: reduced incidence and predictive factors
by: Alessandra Di Francesco, et al.
Published: (2024-01-01)